US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pernix Therapeutics

0.2070

0.0000

Volume:- -

Turnover:- -

Market Cap:3.00M

PE:-0.03

High:0.2070

Open:0.2070

Low:0.2070

Close:0.2070

Loading ...

Overview Company News Filings

Prescient (ASX:PTX) ends last quarter on firm financial footing and key clinical developments

2023 Prepped and Primed: Prescient Therapeutics (ASX:PTX) with CEO and managing director, Steven Yatomi-Clarke

Prescient (ASX:PTX) closes a very productive September quarter, achieving key milestones

Prescient Therapeutics reports positive safety data from PTX-100 study on T-cell lymphoma patients

Prescient Therapeutics (ASX:PTX) unveils new treatment to boost CAR-T performance

The Market Herald

HealthKick Podcast: PTX partners with the US’s largest cancer centre on personalised treatment

Prescient Therapeutics (ASX:PTX) teams up with prestigious cancer centre in the US

Prescient Therapeutics (ASX:PTX) partners with MD Anderson Cancer Center

The Market Herald

90 Seconds With… Steven Yatomi-Clarke, Prescient Therapeutics (ASX:PTX)

Prescient Therapeutics (ASX:PTX) to raise $8m for cancer treatment therapies

The Market Herald

Prescient (ASX: PTX) signs off FY22 with solid progress in clinical pipeline

Prescient Therapeutics (ASX:PTX) signs deal with Thermo Fisher for OmniCAR development

The Market Herald

Prescient Therapeutics Says It Signs Agreement With Thermo Fisher

Prescient Therapeutics (ASX:PTX) locks in OmniCAR cell manufacturing contract for clinical trials

The Market Herald

Webinar Recap - HPC, PTX, AR9 & MEK

Informed Investor

Prescient Therapeutics (ASX: PTX) – Webinar Presentation

Informed Investor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","market":"US","secType":"STK","nameCN":"Pernix Therapeutics","latestPrice":0.207,"timestamp":1552680000000,"preClose":0.207,"halted":0,"volume":0,"delay":0,"floatShares":13322183,"shares":14505848,"eps":-6.260195,"marketStatus":"Closed","change":0,"latestTime":"03-15 16:00:00 EDT","open":0.207,"high":0.207,"low":0.207,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.260195,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":855291600000,"exchange":"NASDAQ","adjPreClose":0.207,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTX\",,,,,undefined,":{"symbol":"PTX","floatShares":13322183,"roa":"--","roe":"--","lyrEps":-7.205398,"shares":14505848,"dividePrice":0,"high":0.207,"amplitude":0,"preClose":0.207,"low":0.207,"week52Low":0.203,"pbRate":"-0.01","week52High":3.3,"institutionHeld":0.7448,"latestPrice":0.207,"eps":-6.260195,"divideRate":0,"volume":0,"delay":0,"ttmEps":-6.260195,"open":0.207,"prevYearClose":0.207},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2308043507","title":"Prescient (ASX:PTX) ends last quarter on firm financial footing and key clinical developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2308043507","media":"Kalkine Media","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308043507?lang=en_us&edition=fundamental","pubTime":"2023-02-01 10:05","pubTimestamp":1675217100,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://kalkinemedia.com/storage/uploads/medium/Picture1_02_01_2023_02_07_57_564432.jpg","type":0,"news_type":0,"thumbnails":["https://kalkinemedia.com/storage/uploads/medium/Picture1_02_01_2023_02_07_57_564432.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://kalkinemedia.com/au/news/featured-news/prescient-asxptx-ends-last-quarter-on-firm-financial-footing-and-key-clinical-developments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kalkinemedia_stock","symbols":["BK7508","PTX","PTX.AU","BK7067"],"gpt_icon":0},{"id":"2305968169","title":"2023 Prepped and Primed: Prescient Therapeutics (ASX:PTX) with CEO and managing director, Steven Yatomi-Clarke","url":"https://stock-news.laohu8.com/highlight/detail?id=2305968169","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2305968169?lang=en_us&edition=fundamental","pubTime":"2023-01-24 07:14","pubTimestamp":1674515674,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2023/01/PAP-2023-Prescient-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2023/01/PAP-2023-Prescient-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/stockhead-tv/2023-prepped-and-primed-prescient-therapeutics-asxptx-with-ceo-and-managing-director-steven-yatomi-clarke/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PTX"],"gpt_icon":0},{"id":"2280361904","title":"Prescient (ASX:PTX) closes a very productive September quarter, achieving key milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2280361904","media":"Kalkine Media","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2280361904?lang=en_us&edition=fundamental","pubTime":"2022-11-01 12:40","pubTimestamp":1667277600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg","type":0,"news_type":0,"thumbnails":["https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://kalkinemedia.com/au/news/featured-news/prescient-asxptx-closes-a-very-productive-september-quarter-achieving-key-milestones","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kalkinemedia_stock","symbols":["PTX.AU","ASX","XAO.AU","BK4141","BK7067","BK7508","BK4526","ASX.AU","XKO.AU","XJO.AU","BK7039","PTX"],"gpt_icon":0},{"id":"2278736985","title":"Prescient Therapeutics reports positive safety data from PTX-100 study on T-cell lymphoma patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2278736985","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2278736985?lang=en_us&edition=fundamental","pubTime":"2022-10-25 21:15","pubTimestamp":1666703721,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://smallcaps.com.au/wp-content/uploads/2022/10/Prescient-Therapeutics-ASX-PTX-PTX-100-trial-Professor-H.-Miles-Prince-Epworth-Hospital-Melbourne-511x400.jpg","type":0,"news_type":0,"thumbnails":["https://smallcaps.com.au/wp-content/uploads/2022/10/Prescient-Therapeutics-ASX-PTX-PTX-100-trial-Professor-H.-Miles-Prince-Epworth-Hospital-Melbourne-511x400.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/prescient-therapeutics-positive-safety-data-ptx-100-study-t-cell-lymphoma-patients/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["PTX"],"gpt_icon":0},{"id":"2269100753","title":"Prescient Therapeutics (ASX:PTX) unveils new treatment to boost CAR-T performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2269100753","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2269100753?lang=en_us&edition=fundamental","pubTime":"2022-09-23 11:36","pubTimestamp":1663904160,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/prescient-therapeutics-asxptx-unveils-new-treatment-to-boost-car-t-performance-2022-09-23/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["CAR","PTX.AU","BK4526","ASX.AU","00699","BK7508","XJO.AU","BK7067","PTX","ASX","XKO.AU","XAO.AU","BK4141","BK4022","BK7039"],"gpt_icon":0},{"id":"2266314015","title":"HealthKick Podcast: PTX partners with the US’s largest cancer centre on personalised treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2266314015","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2266314015?lang=en_us&edition=fundamental","pubTime":"2022-09-12 06:00","pubTimestamp":1662933616,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2022/09/Prescient-Therapeutics-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2022/09/Prescient-Therapeutics-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/healthkick-podcast-ptx-partners-with-the-uss-largest-cancer-centre-on-personalised-treatment/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PTX"],"gpt_icon":0},{"id":"2265832920","title":"Prescient Therapeutics (ASX:PTX) teams up with prestigious cancer centre in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2265832920","media":"Kalkine Media","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2265832920?lang=en_us&edition=fundamental","pubTime":"2022-09-08 11:37","pubTimestamp":1662608220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg","type":0,"news_type":0,"thumbnails":["https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://kalkinemedia.com/au/news/featured-news/prescient-therapeutics-asxptx-teams-up-with-prestigious-cancer-centre-in-the-us","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kalkinemedia_stock","symbols":["XKO.AU","ASX","BK7067","XAO.AU","PTX.AU","BK7508","BK4141","XJO.AU","BK4526","BK7039","PTX","ASX.AU"],"gpt_icon":0},{"id":"2265041494","title":"Prescient Therapeutics (ASX:PTX) partners with MD Anderson Cancer Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2265041494","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2265041494?lang=en_us&edition=fundamental","pubTime":"2022-09-07 10:09","pubTimestamp":1662516540,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/prescient-therapeutics-asxptx-partners-with-md-anderson-cancer-center-2022-09-07/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["PTX","XKO.AU","ASX","BK4141","BK4526","PTX.AU","BK7067","XAO.AU","MD","ASX.AU","BK7039","XJO.AU","BK7508","BK4196"],"gpt_icon":0},{"id":"2263104414","title":"90 Seconds With… Steven Yatomi-Clarke, Prescient Therapeutics (ASX:PTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2263104414","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2263104414?lang=en_us&edition=fundamental","pubTime":"2022-08-31 03:20","pubTimestamp":1661887209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2022/08/90SW-Prescient-Therapeutics-Thumbnail-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2022/08/90SW-Prescient-Therapeutics-Thumbnail-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/stockhead-tv/90-seconds-with-steven-yatomi-clarke-prescient-therapeutics-asxptx/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PTX","BK4141","ASX","BK4526"],"gpt_icon":0},{"id":"2261189396","title":"Prescient Therapeutics (ASX:PTX) to raise $8m for cancer treatment therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2261189396","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2261189396?lang=en_us&edition=fundamental","pubTime":"2022-08-24 12:53","pubTimestamp":1661316780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/prescient-therapeutics-asxptx-to-raise-8m-for-cancer-treatment-therapies-2022-08-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7508","ASX","BK7039","BK4526","PTX.AU","XJO.AU","ASX.AU","BK7067","XAO.AU","XKO.AU","PTX","BK4141"],"gpt_icon":0},{"id":"2261761855","title":"Prescient (ASX: PTX) signs off FY22 with solid progress in clinical pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2261761855","media":"Kalkine Media","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2261761855?lang=en_us&edition=fundamental","pubTime":"2022-08-24 11:37","pubTimestamp":1661312220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":"https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg","type":0,"news_type":0,"thumbnails":["https://kalkinemedia.com/resources/assets/placeholders/350x250.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://kalkinemedia.com/au/sponsored/prescient-asx-ptx-signs-off-fy22-with-solid-progress-in-clinical-pipeline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kalkinemedia_stock","symbols":["XKO.AU","ASX","BK4141","BK4526","PTX.AU","BK7067","XAO.AU","ASX.AU","BK7039","XJO.AU","BK7508","PTX"],"gpt_icon":0},{"id":"2260706808","title":"Prescient Therapeutics (ASX:PTX) signs deal with Thermo Fisher for OmniCAR development","url":"https://stock-news.laohu8.com/highlight/detail?id=2260706808","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2260706808?lang=en_us&edition=fundamental","pubTime":"2022-08-18 10:03","pubTimestamp":1660788180,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/prescient-therapeutics-asxptx-signs-deal-with-thermo-fisher-for-omnicar-development-2022-08-18/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["XKO.AU","ASX","BK7067","XAO.AU","PTX.AU","BK7508","BK4141","XJO.AU","BK4526","BK7039","PTX","ASX.AU"],"gpt_icon":0},{"id":"2260872435","title":"Prescient Therapeutics Says It Signs Agreement With Thermo Fisher","url":"https://stock-news.laohu8.com/highlight/detail?id=2260872435","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2260872435?lang=en_us&edition=fundamental","pubTime":"2022-08-18 09:29","pubTimestamp":1660786153,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTX"],"gpt_icon":0},{"id":"2259607916","title":"Prescient Therapeutics (ASX:PTX) locks in OmniCAR cell manufacturing contract for clinical trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2259607916","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2259607916?lang=en_us&edition=fundamental","pubTime":"2022-08-16 07:59","pubTimestamp":1660607940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketherald.com.au/prescient-therapeutics-asxptx-locks-in-omnicar-cell-manufacturing-contract-for-clinical-trials-2022-08-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4526","BK7039","ASX","XKO.AU","XJO.AU","ASX.AU","BK7067","XAO.AU","PTX.AU","PTX","BK7508","BK4141"],"gpt_icon":0},{"id":"2259066049","title":"Webinar Recap - HPC, PTX, AR9 & MEK","url":"https://stock-news.laohu8.com/highlight/detail?id=2259066049","media":"Informed Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2259066049?lang=en_us&edition=fundamental","pubTime":"2022-08-15 07:21","pubTimestamp":1660519284,"startTime":"0","endTime":"0","summary":"Catch up on the full webinar presentations from The Hydration Pharmaceutical Company (ASX HPC), Prescient Therapeutics (ASX: PTX), archTIS (ASX: AR9) & Meeka Metals (ASX: MEK)","market":"us","thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/f9f9dba4c9bd806e499cbc3a74d9d2cf44348845.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/f9f9dba4c9bd806e499cbc3a74d9d2cf44348845.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2022/08/15/webinar-recap-hpc-ptx-ar9-mek/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"informedinvestor","symbols":["PTX"],"gpt_icon":0},{"id":"2259066046","title":"Prescient Therapeutics (ASX: PTX) – Webinar Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2259066046","media":"Informed Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2259066046?lang=en_us&edition=fundamental","pubTime":"2022-08-15 07:17","pubTimestamp":1660519050,"startTime":"0","endTime":"0","summary":"Steven Yatomi-Clarke - CEO & MD - Prescient Therapeutics is focused on developing novel, personalised therapies for a range of cancers. ","market":"us","thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/bed6c844bb18f01d286482b489ef9dbb41095b73.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/bed6c844bb18f01d286482b489ef9dbb41095b73.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2022/08/15/prescient-therapeutics-asx-ptx-webinar-presentation-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"informedinvestor","symbols":["ASX","PTX","BK4141","BK4526"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"PTX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":-0.89},{"market":"US","date":"2018-08-09","symbol":"PTX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"","actualEps":-1.13},{"market":"US","date":"2018-05-10","symbol":"PTX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"","actualEps":-1.57},{"market":"US","date":"2018-03-08","symbol":"PTX","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1520485200000,"reportTimeType":"","actualEps":-2.78},{"market":"US","date":"2017-11-07","symbol":"PTX","fiscalQuarterEnding":"2017/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTX\",market:\"US\",delay:false,,,undefined,":{}}}